134. Çakaloğlu Y. Kronik viral hepatitlerde güncel tedavi ve izlem, 4. Ulusal İç Hastalıkları Kongresi, 25-29 Eylül 2002, Antalya, Kongre Kitabı 24-27
135. Poynard T, Leroy V, Cohard M, et al. Meta-analaysis of interferon randomized trials İn the treatment of viral hepatitis C: Effects of dese and duration.
136. Manns MP, Gordon SC, Reindollar R, Goodman ZD; Koury K, Ling M Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C Lancet 2001 Sep 22;358(9286):958-65.
137. Knodell RG, Ishak KG, Chen TS, Craig R, Kaplowitz N, Wollman J. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1994; 19: 1513-1520 137. McCormick SE,Sjogren MH. Evaluation of liver histology, ALT
elevation, and HCV RNA titer in patients with chronic hepatitis C. Am J Gastroenterol 1996; 91: 1516-1522 138. Jamal MM, Abdelkarim BZ. Chronic hepatitis C with persistently normal aminotransferase levels: do we have an adequate definition? Am J Gastroenterol 2003; 98: 1455-1456 139. Jamal MM, Soni A, Quinn PG, Wheeler DE, Arora S, Johnston DE. Clinical features of hepatitis C-infected patients with persistently normal alanine transaminase levels in the Southwestern United States. Hepatology 1999; 30: 1307-1311 140. Bacon BR. Iron and hepatitis C. Gut 1997; 41: 127-128. 141. Fargion S, Mattioli M, Fiorelli G. Iron and liver diseases. Can J Gastroenterol 2000;14:89-92. 142. Haap M, Fritsche A, Mensing H, Stumvoll M. Association of high serum ferritin concentration with glucose intolerance and insulin resistance in healthy people. Ann Intern Med 2003; 139:869870.
66



74. SAYFAYA BENZER SAYFALAR

tabs_sener_yagiz_191898 - Sayfa
...


74. SAYFA ICERIGI

134. Çakaloğlu Y. Kronik viral hepatitlerde güncel tedavi ve izlem, 4. Ulusal İç Hastalıkları Kongresi, 25-29 Eylül 2002, Antalya, Kongre Kitabı 24-27
135. Poynard T, Leroy V, Cohard M, et al. Meta-analaysis of interferon randomized trials İn the treatment of viral hepatitis C: Effects of dese and duration.
136. Manns MP, Gordon SC, Reindollar R, Goodman ZD; Koury K, Ling M Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C Lancet 2001 Sep 22;358(9286):958-65.
137. Knodell RG, Ishak KG, Chen TS, Craig R, Kaplowitz N, Wollman J. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1994; 19: 1513-1520 137. McCormick SE,Sjogren MH. Evaluation of liver histology, ALT
elevation, and HCV RNA titer in patients with chronic hepatitis C. Am J Gastroenterol 1996; 91: 1516-1522 138. Jamal MM, Abdelkarim BZ. Chronic hepatitis C with persistently normal aminotransferase levels: do we have an adequate definition? Am J Gastroenterol 2003; 98: 1455-1456 139. Jamal MM, Soni A, Quinn PG, Wheeler DE, Arora S, Johnston DE. Clinical features of hepatitis C-infected patients with persistently normal alanine transaminase levels in the Southwestern United States. Hepatology 1999; 30: 1307-1311 140. Bacon BR. Iron and hepatitis C. Gut 1997; 41: 127-128. 141. Fargion S, Mattioli M, Fiorelli G. Iron and liver diseases. Can J Gastroenterol 2000;14:89-92. 142. Haap M, Fritsche A, Mensing H, Stumvoll M. Association of high serum ferritin concentration with glucose intolerance and insulin resistance in healthy people. Ann Intern Med 2003; 139:869870.
66

İlgili Kaynaklar







single.php